SUBSCRIBE
SUBSCRIBE

Horizon Therapeutics

NEWS
Horizon Therapeutics was acquired by Amgen in 2023.
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Horizon Pharma Acquires Hyperion Therapeutics and Its Revenue-Boosting Pipeline for $1.1B
March 30, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
BioMidwest
Horizon Pharma plc. Moves To Ireland As Frustrated Lawmakers Look On
September 19, 2014
 · 
1 min read
Load More

AWARDS
  • 2022 Best Places to Work
IN THE PRESS
Horizon Therapeutics plc Makes Founding Gift to Support the University of Notre Dame’s Patient Advocacy Initiative
September 16, 2022
 · 
5 min read
Data from the MIRROR Randomized Controlled Trial of KRYSTEXXA® (pegloticase) Injection with Methotrexate Published in Arthritis & Rheumatology
September 14, 2022
 · 
9 min read
Drug Development
Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint
September 12, 2022
 · 
7 min read
BioMidwest
Horizon Therapeutics plc Announces $500 Million Share Repurchase Program
September 9, 2022
 · 
3 min read
Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2022 List
September 8, 2022
 · 
3 min read
Business
Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland
August 29, 2022
 · 
3 min read
Horizon Therapeutics plc to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
August 25, 2022
 · 
1 min read
Business
Q32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune Diseases
August 15, 2022
 · 
5 min read
Business
Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance
August 3, 2022
 · 
43 min read
Business
Horizon Therapeutics plc Named a Best Company for Multicultural Women
July 25, 2022
 · 
3 min read
Load More